Filing Details
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2009-09-16 15:23:42
- Reporting Period:
- 2009-09-14
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1382911 | Orexigen Therapeutics Inc. | OREX | () |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1280249 | Iii K Daniel Turner | C/O Orexigen Therapeutics, Inc 3344 N. Torrey Pines Court, Suite 200 La Jolla CA 92037 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2009-09-15 | 135,701 | $8.96 | 1,539,616 | No | 4 | S | Indirect | By Montreux Equity Partners II, SBIC, LP Montreux Equity Partners III, SBIC, LP, and related funds |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Montreux Equity Partners II, SBIC, LP Montreux Equity Partners III, SBIC, LP, and related funds |
Billionaire Hedge Funds
